Related Experiment Video
Updated: Jun 24, 2026
09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Major recent trials in cardiovascular diseases.
Surya M Artham1, Carl J Lavie, Paul W McMullan
1Ochsner Medical Center, New Orleans, LA 70121-2483, USA.
Postgraduate Medicine
|April 1, 2009
Summary
This review covers recent cardiovascular disease clinical trials, focusing on primary prevention, heart failure treatments, and stroke risk factors. It highlights new therapies and interventions for conditions like myocardial infarction and arrhythmias.
Area of Science:
- Cardiology
- Clinical Trials
- Preventive Medicine
Background:
- Cardiovascular diseases remain a leading cause of mortality globally.
- Advances in understanding disease mechanisms necessitate ongoing clinical research.
- Primary prevention strategies are crucial for reducing cardiovascular event incidence.
Purpose of the Study:
- To review and comment on recent clinical trials in cardiovascular disease.
- To highlight novel therapeutic advances and investigational agents.
- To explore the impact of various factors on cardiovascular events and stroke.
Main Methods:
- Review of recent clinical trial data and published reports.
- Focus on primary prevention, heart failure, arrhythmias, and stroke.
- Analysis of interventional cardiology trials and registry data.
Main Results:
- Exploration of lipid, hypertension, and diabetes management trials.
- Discussion of new devices and agents for heart failure.
- Evaluation of investigational agents for arrhythmias and stroke risk factors.
Conclusions:
- Emerging data on novel treatments for myocardial infarction and heart failure.
- Comparative analyses of interventions for patients with diabetes.
- Insights into long-term outcomes of dual antiplatelet therapy and stroke prevention.
Related Concept Videos
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...